Signaling and epigenetic regulation of pituitary development

Current Opinion in Cell Biology

Volumn 19, Issue 6, 2007, Pages 605-611

  Zhu, Xiaoyan ^a   Wang, Jianxun ^a   Ju, Bong Gun ^a   Rosenfeld, Michael G ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; HISTONE; PROTEIN LSD1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HYPOPHYSIS; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; PITUITARY GLAND; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 36749011176     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.09.011     Document Type: Review

References (61)

1. Cushman L.J., and Camper S.A. Molecular basis of pituitary dysfunction in mouse and human. Mamm Genome 12 (2001) 485-494
2. Scully K.M., and Rosenfeld M.G. Pituitary development: regulatory codes in mammalian organogenesis. Science 295 (2002) 2231-2235
3. Zhu X., Gleiberman A.S., and Rosenfeld M.G. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev 87 (2007) 933-963
4. Camper S.A., Saunders T.L., Katz R.W., and Reeves R.H. The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 8 (1990) 586-590
5. Li S., Crenshaw III E.B., Rawson E.J., Simmons D.M., Swanson L.W., and Rosenfeld M.G. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 (1990) 528-533
6. Gage P.J., Brinkmeier M.L., Scarlett L.M., Knapp L.T., Camper S.A., and Mahon K.A. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 10 (1996) 1570-1581
7. Sornson M.W., Wu W., Dasen J.S., Flynn S.E., Norman D.J., O'Connell S.M., Gukovsky I., Carriere C., Ryan A.K., Miller A.P., et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384 (1996) 327-333
8. Pulichino A.M., Vallette-Kasic S., Couture C., Gauthier Y., Brue T., David M., Malpuech G., Deal C., Van Vliet G., De Vroede M., et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 17 (2003) 711-716
9. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7 (2006) 678-689
10. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 284 (1999) 770-776
11. Lai E.C. Notch signaling: control of cell communication and cell fate. Development 131 (2004) 965-973
12. Nam Y., Sliz P., Song L., Aster J.C., and Blacklow S.C. Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 124 (2006) 973-983
13. Wilson J.J., and Kovall R.A. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell 124 (2006) 985-996
14. Wallberg A.E., Pedersen K., Lendahl U., and Roeder R.G. p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 22 (2002) 7812-7819
15. Fryer C.J., White J.B., and Jones K.A. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16 (2004) 509-520
16. Krejci A., and Bray S. Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev 21 (2007) 1322-1327
17. Kao H.Y., Ordentlich P., Koyano-Nakagawa N., Tang Z., Downes M., Kintner C.R., Evans R.M., and Kadesch T. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 12 (1998) 2269-2277
18. Oswald F., Winkler M., Cao Y., Astrahantseff K., Bourteele S., Knochel W., and Borggrefe T. RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. Mol Cell Biol 25 (2005) 10379-10390
19. Oswald F., Kostezka U., Astrahantseff K., Bourteele S., Dillinger K., Zechner U., Ludwig L., Wilda M., Hameister H., Knochel W., et al. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. EMBO J 21 (2002) 5417-5426
20. Nagel A.C., Krejci A., Tenin G., Bravo-Patino A., Bray S., Maier D., and Preiss A. Hairless-mediated repression of notch target genes requires the combined activity of Groucho and CtBP corepressors. Mol Cell Biol 25 (2005) 10433-10441
21. Iso T., Kedes L., and Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194 (2003) 237-255
22. + precursors is necessary for the emergency of distinct Pit1 lineages. Further studies reveal the function of Math3 in somatotropes maturation and proliferation.
23. Kita A., Imayoshi I., Hojo M., Kitagawa M., Kokubu H., Ohsawa R., Ohtsuka T., Kageyama R., and Hashimoto N. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol 21 (2007) 1458-1466
24. Raetzman L.T., Cai J.X., and Camper S.A. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 304 (2007) 455-466
25. Jadhav A.P., Mason H.A., and Cepko C.L. Notch 1 inhibits photoreceptor production in the developing mammalian retina. Development 133 (2006) 913-923
26. Yaron O., Farhy C., Marquardt T., Applebury M., and Ashery-Padan R. Notch1 functions to suppress cone-photoreceptor fate specification in the developing mouse retina. Development 133 (2006) 1367-1378
27. Peng C.Y., Yajima H., Burns C.E., Zon L.I., Sisodia S.S., Pfaff S.L., and Sharma K. Notch and MAML signaling drives Scl-dependent interneuron diversity in the spinal cord. Neuron 53 (2007) 813-827
28. Ohlstein B., and Spradling A. Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential notch signaling. Science 315 (2007) 988-992
29. Ward R.D., Davis S.W., Cho M., Esposito C., Lyons R.H., Cheng J.F., Rubin E.M., Rhodes S.J., Raetzman L.T., Smith T.P., et al. Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene. Mamm Genome 18 (2007) 521-537. Using a comparative genomics approach, the authors identify three evolutionarily conserved putative regulatory elements in the Prop1 gene. They further demonstrate that all three elements have enhancer activities and the first intronic region is capable of conferring dorsal expression of a trangene.
30. ••], these studies demonstrate downregulation of Notch signaling in later stages of pituitary development is essential for cells to undergo terminal differentiation.
31. Liu J., Lin C., Gleiberman A., Ohgi K.A., Herman T., Huang H.P., Tsai M.J., and Rosenfeld M.G. Tbx19, a tissue-selective regulator of POMC gene expression. Proc Natl Acad Sci U S A 98 (2001) 8674-8679
32. Gordon M.D., and Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281 (2006) 22429-22433
33. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127 (2006) 469-480
34. Olson L.E., Tollkuhn J., Scafoglio C., Krones A., Zhang J., Ohgi K.A., Wu W., Taketo M.M., Kemler R., Grosschedl R., et al. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 125 (2006) 593-605. This study demonstrates that β-catenin functions as a cofactor of Prop1 in activating Pit1 and repressing Hesx1 expression during pituitary development, revealing a novel regulatory mechanism integrating Wnt/β-catenin signaling in a tissue-specific manner.
35. Brinkmeier M.L., Potok M.A., Cha K.B., Gridley T., Stifani S., Meeldijk J., Clevers H., and Camper S.A. TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 17 (2003) 2152-2161
36. Treier M., Gleiberman A.S., O'Connell S.M., Szeto D.P., McMahon J.A., McMahon A.P., and Rosenfeld M.G. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12 (1998) 1691-1704
37. Cha K.B., Douglas K.R., Potok M.A., Liang H., Jones S.N., and Camper S.A. WNT5A signaling affects pituitary gland shape. Mech Dev 121 (2004) 183-194
38. Goldberg A.D., Allis C.D., and Bernstein E. Epigenetics: a landscape takes shape. Cell 128 (2007) 635-638
39. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
40. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441 (2006) 349-353
41. Kwon Y.S., Garcia-Bassets I., Hutt K.R., Cheng C.S., Jin M., Liu D., Benner C., Wang D., Ye Z., Bibikova M., et al. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc Natl Acad Sci U S A 104 (2007) 4852-4857
42. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., Ju B.G., Ohgi K.A., Wang J., Escoubet-Lozach L., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128 (2007) 505-518
43. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
44. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
45. Surani M.A., Hayashi K., and Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 128 (2007) 747-762
46. Scully K.M., Jacobson E.M., Jepsen K., Lunyak V., Viadiu H., Carriere C., Rose D.W., Hooshmand F., Aggarwal A.K., and Rosenfeld M.G. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290 (2000) 1127-1131
47. Wang J., Scully K., Zhu X., Cai L., Zhang J., Prefontaine G.G., Krones A., Ohgi K.A., Zhu P., Garcia-Bassets I., et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446 (2007) 882-887. This work demonstrates that LSD1 is specifically required in late cell-lineage determination and terminal differentiation events during pituitary organogenesis. As a component of either MLL1-containing co-activator complex or CtBP-CoREST co-repressor complex, LSD1 is recruited to the promoters of a cohort of genes, regulating activation and repression programs that are associated with cell-lineage specification.
48. Pulichino A.M., Vallette-Kasic S., Tsai J.P., Couture C., Gauthier Y., and Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17 (2003) 738-747
49. Lamolet B., Pulichino A.M., Lamonerie T., Gauthier Y., Brue T., Enjalbert A., and Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104 (2001) 849-859
50. Zhao L., Bakke M., Krimkevich Y., Cushman L.J., Parlow A.F., Camper S.A., and Parker K.L. Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 128 (2001) 147-154
51. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., Gunther T., Buettner R., and Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 (2005) 436-439
52. Lan F., Zaratiegui M., Villen J., Vaughn M.W., Verdel A., Huarte M., Shi Y., Gygi S.P., Moazed D., Martienssen R.A., et al. S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription. Mol Cell 26 (2007) 89-101
53. Luque R.M., Amargo G., Ishii S., Lobe C., Franks R., Kiyokawa H., and Kineman R.D. Reporter expression, induced by a growth hormone promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland. Endocrinology 148 (2007) 1946-1953. Using Cre-mediated lineage tracing assay, this study reveals that most of lactotropes arise independently of somatotropes.
54. Lee M.G., Wynder C., Cooch N., and Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437 (2005) 432-435
55. Shi Y.J., Matson C., Lan F., Iwase S., Baba T., and Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19 (2005) 857-864
56. Yang M., Gocke C.B., Luo X., Borek D., Tomchick D.R., Machius M., Otwinowski Z., and Yu H. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol Cell 23 (2006) 377-387
57. Ho Y., Elefant F., Liebhaber S.A., and Cooke N.E. Locus control region transcription plays an active role in long-range gene activation. Mol Cell 23 (2006) 365-375. The authors show that in the human GH LCR region, there are intergenic non-coding transcripts. They further demonstrate that blocking LCR transcription leads to reduced downstream hGH expression. A Pol II tracking model is proposed to regulate long-distance transcriptional activation.
58. Ho Y., Liebhaber S.A., and Cooke N.E. Activation of the human GH gene cluster: roles for targeted chromatin modification. Trends Endocrinol Metab 15 (2004) 40-45
59. Lunyak V.V., Prefontaine G.G., Nunez E., Cramer T., Ju B.G., Ohgi K.A., Hutt K., Roy R., Garcia-Diaz A., Zhu X., et al. Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. Science 317 (2007) 248-251. The author identify an upstream SINE B2 repeat in the mouse GH locus that can generate overlapping Pol II and Pol III-driven transcripts and have enhancer-blocking activity in cells. During pituitary development, activation of the Pol II transcripts is correlated with the transition of GH locus from heterochromatin domain to euchromatin territory. They further demonstrate that the SINE B2 element is required for the BAC transgene expression.
60. Scott K.C., Merrett S.L., and Willard H.F. A heterochromatin barrier partitions the fission yeast centromere into discrete chromatin domains. Curr Biol 16 (2006) 119-129
61. Ho Y., Elefant F., Cooke N., and Liebhaber S. A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol Cell 9 (2002) 291-302